NuGenerex Drug Delivery Systems

NuGenerex Drug Delivery Systems is a subsidiary of Generex Biotechnology Corporation focused on the development and commercialization of drug delivery technologies. The company's flagship platform, RapidMist, is a proprietary metered-dose buccal spray system designed to deliver biologics and small molecules through the oral mucosa directly into the bloodstream. Their lead product candidate, Generex Oral-lyn, is an oral insulin spray that has undergone Phase 3 clinical trials for the treatment of diabetes. Beyond insulin, the company explores the application of its delivery technology for other therapeutic areas including pain management and vaccine delivery.